List of Figures
Figure 2.1 Prevalence of HIV/Aids In Major Countries
Figure 2.2 Incidence Of Hiv Across Various Countries
Figure 2.3 Incidence of Hepatitis Forecast (2017-2027)
Figure 2.4 Forecasted Cases Of Tuberculosis (2017-2027)
Figure 2.5 Forecasted Cases Of Malaria (2017-2027)
Figure 2.6 Forecasted Cases Of Chlamydia (2017-2027)
Figure 3.1 Percentage Contribution Of Individual Segment- 2017
Figure 3.2 Percentage Contribution Of Individual Segment- 2027
Figure 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, 2017-2027
Figure 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.5 Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.1.: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.2: Global Infectious Disease Diagnostics end user: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 4.4: Infectious Disease Diagnostics End-User Market Share (%) 2017
Figure 4.5: Infectious Disease Diagnostics End-User Market Share (%) 2027
Figure 5.1. Infectious Disease Diagnostics Market, Regional Market Share, 2017 (%)
Figure 5.2. Infectious Disease Diagnostics Market, Regional Market Share, 2027 (%)
Figure 5.3: US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR %) 2017-2027
Figure 5.4: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Figure 5.5: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.6: EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR %) 2017-2027
Figure 5.7. Infectious Disease Diagnostics market, Disease cases, 2017-2027, EU-5
Figure 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.9: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.10: Japanese Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.11. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Figure 5.12: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 5.13: BRIC Infectious Disease Diagnostics Market Forecast, By Market (Revenue, $bn, AGR %) 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn) 2017-2027
Figure 7.1 Porter’s Five Forces Analysis for the Infectious Disease Diagnostics Market

List of Tables
Table 2.1 Prevalence Forecast of HIV/AIDS in major countries (Mn, 2017-2027)
Table 2.2 Incidence of HIV across various countries (2017-2027)
Table 2.3 Incidence of Hepatitis Forecast (2017-2027)
Table 2.4 Forecasted Incidence Of Tuberculosis (2017-2027)
Table 2.5 Forecasted Incidences of Malaria (2017-2027)
Table 2.6 Incidences of Chlamydia (2017-2027)
Table 3.1 infectious disease diagnoses By Share (%, 2017)
Table 3.2 infectious disease diagnoses By Share (%, 2027)
Table 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, and CAGR %, 2017-2027
Table 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.5: Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.1: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.2: Global Infectious Disease Diagnostics: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.1 : Infectious Disease Diagnostics Market Forecast, (Geographical Distribution, $bn, AGR %) 2017-2027
Table 5.2 : US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.3: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Table 5.4: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.5 : EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.6: EU-5 Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027
Table 5.7: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.9. Japanese Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.10. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Table 5.11: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.12: BRIC Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.13 : BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Table 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 6.1 Abbott Laboratories– Key Facts
Table 6.2 Abbott Recent Financials
Table 6.3 Becton, Dickinson and Company– Key Facts
Table 6.4 Becton, Dickinson and Company Recent Financials
Table 6.5 bioMérieux S.A. – Key Facts
Table 6.6 bioMérieux S.A.Recent Financials
Table 6.7 Bio-Rad – Key Facts
Table 6.8 Bio-Rad – Recent Financials
Table 6.9 Alere – Key Facts
Table 6.10 Alere – Recent Financials
Table 6.11 Siemens Healthcare – Key Facts
Table 6.12 Siemens Healthcare – Recent Financials
Table 6.13 Roche Diagnostics – Key Facts
Table 6.14 Danaher Corporation– Key Facts
Table 6.15 Danaher Corporation.– Recent Financials
Table 6.16 Thermo Fisher Scientific Inc.– Key Facts
Table 6.17 Thermo Fisher Scientific Inc.– Recent Financials
Table 6.18: Companies of interest in the Infectious Disease Diagnostics Market